Skip to main content
. 2020 Mar 26;56(6):1468–1478. doi: 10.3892/ijo.2020.5028

Table I.

Clinicopathological characteristics of 70 patients with gastrointestinal stromal tumour.

Clinicopathological characteristic n (%)
Sex
 Male 32 (45.7)
 Female 38 (54.3)
Age
 Median, years 65
 Range, years 34-89
 ≤60 years 28 (40.0)
 >60 years 42 (60.0)
Curative resection
 Yes 13 (18.6)
 No 57 (81.4)
Imatinib therapy
 Yes 70 (100.0)
 No 0 (0.0)
Outcome
 Alive 21 (30.0)
 Dead 49 (70.0)
Primary tumour location
 Oesophagus 2 (2.9)
 Stomach 33 (47.1)
 Small intestine 25 (35.7)
 Rectum 6 (8.6)
 Extraluminal 4 (5.7)
Mitotic index,/50 HPF
 ≤5 22 (31.4)
 5.1-10 11 (15.7)
 >10 37 (52.9)
Primary tumour size, cm
 0-5 6 (8.5)
 5.1-10 23 (32.9)
 >10 37 (52.9)
 Unknown 4 (5.7)
Risk classificationa
 High 49 (70.0)
 Intermediate 11 (15.7)
 Low 9 (12.9)
 Very low 1 (1.4)
Morphology
 Spindle cells 47 (67.1)
 Epithelioid cells 8 (11.5)
 Mixed cells 15 (21.4)
a

Risk groups for gastrointestinal tumours were adapted from Miettinen et al (4).